Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 17: Ode To The Oncopig with Jessicca Rege
Summary
Welcome to The Pharmaverse Podcast, your go-to destination for insights in the pharmaceutical and biotech industry. In this episode, host Michael Pietrack sits down with Jessicca Rege, PhD, CEO of Seuss Clinicals, to discuss pioneering approaches in preclinical oncology research using the Oncopig cancer model.
Jessica shares her experience leading innovative pharma projects, her thoughts on disruptive and transformational leadership, and practical advice for aspiring leaders in the pharmaceutical and biotech sectors. Learn how her team is advancing preclinical oncology research, moving therapies to patients faster, and redefining leadership in Pharma.
Subscribe to stay updated with the latest episodes and gain insights from the brightest stars across the Pharma universe!
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD